May, C. D., Garnett, J., Ma, X., Landers, S. M., Ingram, D. R., Demicco, E. G., . . . Torres, K. E. (2015). AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas. BMC Cancer.
Stile di citazione ChicagoMay, Caitlin D., et al. "AXL Is a Potential Therapeutic Target in Dedifferentiated and Pleomorphic Liposarcomas." BMC Cancer 2015.
Citazione MLAMay, Caitlin D., et al. "AXL Is a Potential Therapeutic Target in Dedifferentiated and Pleomorphic Liposarcomas." BMC Cancer 2015.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.